Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Healthtech Industry Analysis

UpdatedMay 31, 2026
DataAggregated Company Financials
Companies1
  • 7D5.0%
  • 3M22.9%
  • 1Y62.7%
  • YTD59.5%

Over the last 7 days, the Healthtech industry has risen 5.7%, driven by gains from every company within the industry. In the last 12 months, the industry was up 74%. Looking forward, earnings are forecast to grow by 5.4% annually.

Industry Valuation and Performance

Has the Swiss Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 31 May 2026CHF 207.0mCHF 292.1mCHF 15.1m13.7x13.7x0.7x
Tue, 28 Apr 2026CHF 180.0mCHF 292.1mCHF 15.1m11.9x11.9x0.6x
Thu, 26 Mar 2026CHF 178.3mCHF 292.1mCHF 15.1m11.8x11.8x0.6x
Sat, 21 Feb 2026CHF 184.3mCHF 284.6mCHF 3.0m61.4x61.4x0.6x
Mon, 19 Jan 2026CHF 147.3mCHF 284.6mCHF 3.0m49.1x49.1x0.5x
Wed, 17 Dec 2025CHF 422.5mCHF 284.6mCHF 3.0m43.2x140.8x1.5x
Fri, 14 Nov 2025CHF 129.3mCHF 284.6mCHF 3.0m43.1x43.1x0.5x
Sun, 12 Oct 2025CHF 134.3mCHF 284.6mCHF 3.0m44.8x44.8x0.5x
Tue, 09 Sep 2025CHF 155.2mCHF 284.6mCHF 3.0m51.7x51.7x0.5x
Thu, 07 Aug 2025CHF 146.9mCHF 284.6mCHF 3.0m49x49x0.5x
Sat, 05 Jul 2025CHF 136.5mCHF 286.7mCHF 3.7m36.9x36.9x0.5x
Mon, 02 Jun 2025CHF 133.8mCHF 286.7mCHF 3.7m36.2x36.2x0.5x
Wed, 30 Apr 2025CHF 112.6mCHF 286.7mCHF 3.7m30.4x30.4x0.4x
Fri, 28 Mar 2025CHF 128.6mCHF 286.7mCHF 3.7m34.8x34.8x0.4x
Sun, 23 Feb 2025CHF 136.5mCHF 289.2mCHF 15.2m9x9x0.5x
Tue, 21 Jan 2025CHF 150.9mCHF 289.2mCHF 15.2m9.9x9.9x0.5x
Thu, 19 Dec 2024CHF 145.1mCHF 289.2mCHF 15.2m9.5x9.5x0.5x
Sat, 16 Nov 2024CHF 157.5mCHF 289.2mCHF 15.2m10.4x10.4x0.5x
Mon, 14 Oct 2024CHF 190.4mCHF 289.2mCHF 15.2m12.5x12.5x0.7x
Wed, 11 Sep 2024CHF 198.3mCHF 289.2mCHF 15.2m13x13x0.7x
Fri, 09 Aug 2024CHF 199.0mCHF 289.2mCHF 15.2m13.1x13.1x0.7x
Sun, 07 Jul 2024CHF 276.6mCHF 297.3mCHF 17.4m15.9x15.9x0.9x
Tue, 04 Jun 2024CHF 292.4mCHF 297.3mCHF 17.4m16.8x16.8x1x
Thu, 02 May 2024CHF 265.8mCHF 297.3mCHF 17.4m15.3x15.3x0.9x
Sat, 30 Mar 2024CHF 295.6mCHF 297.3mCHF 17.4m17x17x1x
Mon, 26 Feb 2024CHF 262.5mCHF 303.8mCHF 18.4m14.3x14.3x0.9x
Wed, 24 Jan 2024CHF 264.3mCHF 303.8mCHF 18.4m14.4x14.4x0.9x
Fri, 22 Dec 2023CHF 288.0mCHF 303.8mCHF 18.4m15.7x15.7x0.9x
Sun, 19 Nov 2023CHF 359.8mCHF 303.8mCHF 18.4m19.6x19.6x1.2x
Tue, 17 Oct 2023CHF 367.0mCHF 303.8mCHF 18.4m19.9x19.9x1.2x
Thu, 14 Sep 2023CHF 367.0mCHF 303.8mCHF 18.4m19.9x19.9x1.2x
Sat, 12 Aug 2023CHF 427.3mCHF 303.8mCHF 18.4m23.2x23.2x1.4x
Mon, 10 Jul 2023CHF 390.7mCHF 297.4mCHF 11.0m35.5x35.5x1.3x
Wed, 07 Jun 2023CHF 353.0mCHF 297.4mCHF 11.0m32.1x32.1x1.2x
Price to Earnings Ratio

32.1x


Total Market Cap: CHF 353.0mTotal Earnings: CHF 11.0mTotal Revenue: CHF 297.4mTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthtech Industry Price to Earnings3Y Average 25.3x202420252026
Current Industry PE
    There is only one company in the Swiss Healthcare Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Healthcare Services industry have grown 11% per year over the last three years, while revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market0.61%
Healthcare-0.72%
Healthtech5.03%
Healthtech5.03%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ASCN Ascom HoldingCHF 6.065.0%
+CHF 9.9m		62.7%PE13.7x

Latest News

ASCN
CHF 6.06
Ascom Holding
7D
5.0%
1Y
62.7%
Narrative Update • May 29

ASCN: Share Buyback And Dividend Policy Will Support Future Upside Potential

Analysts maintain their headline fair value for Ascom Holding at CHF 7.90 while refining underlying model inputs, such as a slightly lower discount rate and modestly adjusted forward P/E assumptions. Together, these revisions shape an updated price target narrative without changing the stated CHF level.